| Status: | Phase 2 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | F68WAH6N5E |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Polycythemia; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential; Thrombocytosis | Phase 2 | ClinicalTrials |
| Glaucoma | Phase 2 | ClinicalTrials |
| Fibrosis; Idiopathic Interstitial Pneumonias; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis | Phase 2 | ClinicalTrials |
| Fibrosis; Idiopathic Interstitial Pneumonias; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis | Phase 1 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1387453-03-3 |
| ChEMBL | CHEMBL4297814 |
| FDA SRS | F68WAH6N5E |
CONTENTS